Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
NCLH
|
Russell W Galbut
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,017 Added 8.2% |
-
|
Jan 04
2016 |
|
NCLH
|
Chad A Leat
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,879 Added 30.4% |
-
|
Jan 04
2016 |
|
NCLH
|
Walter L Revell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,155 Added 12.69% |
-
|
Jan 04
2016 |
|
NCLH
|
F Robert Salerno
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,155 Added 19.86% |
-
|
Jan 04
2016 |
|
KWR
|
Jeffry D Frisby
Director |
SELL
Bona fide gift
|
Direct | 600 Reduced 5.75% |
-
|
Jan 04
2016 |
|
INTU
|
Edward A Kangas
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 100.0% |
$935,300
$93.53 p/Share
|
Jan 04
2016 |
|
INTU
|
Edward A Kangas
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 50.0% |
$292,300
$29.23 p/Share
|
Jan 04
2016 |
|
CVS
|
Anne A. Finucane
Director |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 11.96% |
$191,740
$95.87 p/Share
|
Jan 04
2016 |
|
ADBE
|
Shantanu Narayen
Chair and CEO |
SELL
Open market or private sale
|
Indirect | 22,422 Reduced 3.77% |
$2,050,268
$91.44 p/Share
|
Jan 04
2016 |
|
ADBE
|
Shantanu Narayen
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect | 22,422 Added 6.98% |
$763,021
$34.03 p/Share
|
Jan 04
2016 |
|
CMCSA
|
Kenneth J Bacon
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,639 Added 21.49% |
-
|
Jan 04
2016 |
|
CMCSA
|
J Michael Cook
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 9,231 Added 21.72% |
-
|
Jan 04
2016 |
|
CCK
|
John W Conway
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 33,864 Reduced 2.2% |
$1,685,073
$49.76 p/Share
|
Jan 04
2016 |
|
CCK
|
Timothy J Donahue
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,384 Reduced 0.93% |
$118,628
$49.76 p/Share
|
Jan 04
2016 |
|
CCK
|
Gerard H Gifford
EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,886 Reduced 2.22% |
$93,847
$49.76 p/Share
|
Jan 04
2016 |
|
CCK
|
Thomas A Kelly
Senior Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,347 Reduced 1.79% |
$67,027
$49.76 p/Share
|
Jan 04
2016 |
|
CCK
|
Djalma Novaes Jr
President - Americas Division |
SELL
Payment of exercise price or tax liability
|
Direct | 631 Reduced 4.09% |
$31,399
$49.76 p/Share
|
Jan 04
2016 |
|
TMUS
|
Larry L Myers
EVP, Human Resources |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 2.14% |
$116,580
$38.86 p/Share
|
Jan 04
2016 |
|
CMCSA
|
Johnathan A Rodgers
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 10,161 Added 32.92% |
-
|
Jan 04
2016 |
|
SPOK
|
Nathaniel Blair Butterfield
Director |
BUY
Grant, award, or other acquisition
|
Direct | 819 Added 8.29% |
$15,004
$18.32 p/Share
|
Jan 04
2016 |
|
SPOK
|
Nicholas A Gallopo
Director |
BUY
Grant, award, or other acquisition
|
Direct | 955 Added 2.58% |
$17,496
$18.32 p/Share
|
Jan 04
2016 |
|
SPOK
|
Stacia Hylton
Director |
BUY
Grant, award, or other acquisition
|
Direct | 819 Added 36.21% |
$15,004
$18.32 p/Share
|
Jan 04
2016 |
|
SPOK
|
Brian Oreilly
Director |
BUY
Grant, award, or other acquisition
|
Direct | 819 Added 3.84% |
$15,004
$18.32 p/Share
|
Jan 04
2016 |
|
SPOK
|
Matthew Oristano
Director |
BUY
Grant, award, or other acquisition
|
Direct | 819 Added 3.78% |
$15,004
$18.32 p/Share
|
Jan 04
2016 |
|
SPOK
|
Samme L Thompson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 819 Added 2.61% |
$15,004
$18.32 p/Share
|
Jan 04
2016 |
|
SPOK
|
Royce Yudkoff
Director |
BUY
Grant, award, or other acquisition
|
Direct | 819 Added 2.52% |
$15,004
$18.32 p/Share
|
Jan 04
2016 |
|
PEN
|
Daniel Donen Davis
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,818 Reduced 5.77% |
$259,257
$53.81 p/Share
|
Jan 02
2016 |
|
PEN
|
Lynn Rothman
EVP and Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,818 Reduced 2.16% |
$259,257
$53.81 p/Share
|
Jan 02
2016 |
|
CVS
|
Helena Foulkes
EVP & President-CVS Pharmacy |
SELL
Payment of exercise price or tax liability
|
Direct | 748 Reduced 2.28% |
$72,152
$96.46 p/Share
|
Jan 02
2016 |
|
HZNP
|
Timothy P Walbert
Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 30,845 Reduced 10.73% |
$668,411
$21.67 p/Share
|
Jan 02
2016 |
|
HZNP
|
Timothy P Walbert
Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 81,675 Added 22.13% |
-
|
Jan 02
2016 |
|
HZNP
|
Jeffrey W Sherman
EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 8,576 Reduced 5.28% |
$185,842
$21.67 p/Share
|
Jan 02
2016 |
|
HZNP
|
Jeffrey W Sherman
EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 26,750 Added 14.15% |
-
|
Jan 02
2016 |
|
HZNP
|
Brian K Beeler
EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 3,741 Reduced 12.41% |
$81,067
$21.67 p/Share
|
Jan 02
2016 |
|
HZNP
|
Brian K Beeler
EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 11,200 Added 27.09% |
-
|
Jan 02
2016 |
|
CSCO
|
Pankaj Patel
EVP, Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 39,471 Reduced 6.88% |
$1,072,032
$27.16 p/Share
|
Jan 01
2016 |
|
PLXS
|
Ralf R Boer
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 4,953 Added 31.14% |
-
|
Jan 01
2016 |
|
PLXS
|
Stephen P Cortinovis
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,953 Added 10.1% |
-
|
Jan 01
2016 |
|
PLXS
|
Mary A Winston
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,000 Added 12.45% |
-
|
Jan 01
2016 |
|
NCR
|
Blackstone Inc
> 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect | 2,996 Added 50.0% |
-
|
Jan 01
2016 |
|
IBCP
|
William J Boer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 453 Added 1.9% |
$6,899
$15.23 p/Share
|
Jan 01
2016 |
|
IBCP
|
Terry L Haske
Director |
BUY
Grant, award, or other acquisition
|
Direct | 168 Added 0.51% |
$2,559
$15.23 p/Share
|
Jan 01
2016 |
|
COP
|
Matthew J Fox
Executive Vice President & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 13,574 Reduced 23.54% |
$631,734
$46.54 p/Share
|
Jan 01
2016 |
|
COP
|
Matthew J Fox
Executive Vice President & COO |
BUY
Exercise of conversion of derivative security
|
Direct | 39,551 Added 40.68% |
-
|
Jan 01
2016 |
|
IRDM
|
S. Scott Smith
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 943 Reduced 1.23% |
$7,931
$8.41 p/Share
|
Jan 01
2016 |
|
IRDM
|
Thomas Fitzpatrick
CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 893 Reduced 0.99% |
$7,510
$8.41 p/Share
|
Jan 01
2016 |
|
COST
|
Richard A Galanti
Executive Vice President |
SELL
Bona fide gift
|
Direct | 800 Reduced 2.55% |
-
|
Dec 31
2015 |
|
TMUS
|
Gary King
EVP and CIO |
BUY
Grant, award, or other acquisition
|
Direct | 32,458 Added 32.57% |
-
|
Dec 31
2015 |
|
TMUS
|
G Michael Sievert
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 71,701 Reduced 21.74% |
$2,804,943
$39.12 p/Share
|
Dec 31
2015 |
|
TMUS
|
G Michael Sievert
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 170,919 Added 34.13% |
-
|
Dec 31
2015 |